Abstract
Twenty patients with angiosarcoma of the scalp who had been treated at our hospital between 1988 and 2008 were reviewed. The average age was 70.8 years old (range : 30-90 years), and the male/female ratio was 14 : 6. The median survival period was 21.4 months. Fourteen patients had developed distant metastasis, ten had developed lung metastasis, and six had developed cervical lymph node metastasis. Eleven patients underwent surgery and sixteen patients underwent IL-2 therapy and radiotherapy. Nine patients underwent chemotherapy ; we currently use Docetaxel chemotherapy as an adjuvant therapy after surgical excision. We suggest that local recurrence is not associated with survival time, and taxoid chemotherapy is useful for the control of distant metastasis.[Skin Cancer (Japan) 2009 ; 24 : 363-368]
